Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Precision Cancer Therapeutics, 2022
... 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually. The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, ... Read More
-
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Kaposi Sarcoma (Infectious Disease) pipeline landscape. Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and ... Read More
-
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape. Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the ... Read More
-
Asia-Pacific Cancer Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... routine care in many healthcare facilities and had an impact on healthcare systems all around the world, putting susceptible cancer patients in serious danger. The strict lockdowns and government regulations intended to slow down the ... Read More
-
PEGylated Proteins Market Size, Share & Trends Analysis Report By Protein Type (CSF, Interferons), By Application (Cancer, Hepatitis), By Product & Services (Consumables, Services), By End-user, And Segment Forecasts, 2022 - 2030
... Growth & Trends The global PEGylated proteins market size is expected to reach USD 3.06 billion by 2030, registering a CAGR of 11.71% over the forecast period, according to a new report by Grand View ... Read More
-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Leukemia (CML, Chronic Myeloid Leukemia) - Drugs In Development, 2022, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, ... Read More
-
Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Gallbladder Cancer (Oncology) pipeline landscape. Gallbladder cancer is a cancer that starts in the gallbladder. Symptoms include abdominal pain, nausea and/or vomiting, jaundice, loss of appetite, fever, itchy skin, dark ... Read More
-
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape. Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of ... Read More
-
Oncology Clinical Trials Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... pandemic had a potential economic impact and implications on most sectors, including the pharmaceutical and biotech industries. COVID-19 had a notable impact on the oncology clinical trials market because cancer clinical trial numbers were decreased ... Read More
-
Oncology Nutrition Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... the market for oncology nutrition. For instance, per the article published in 2022 under the title “Nutrition in Cancer Patients Positive for COVID-19; Case Series and a Systematic Review of Literature”, the study focused on ... Read More
-
Breast Cancer Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... of COVID-19, the market has faced a slight setback, owing to the delay in diagnoses, shortages of drugs, and unavailability of healthcare professionals. According to an article published in the JAMA Network in August 2020, ... Read More
-
Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Vaginal Cancer (Oncology) pipeline landscape. Vaginal cancer is a rare cancer that occurs in vagina. Symptoms includes watery vaginal discharge, a lump or mass in vagina, painful urination, constipation and ... Read More
-
Immunotherapy Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... on the immunotherapy drugs market as the sudden outbreak of the pandemic increased the demand for immunotherapy drugs for the treatment of COVID-19 owing to their safety and efficacy. For instance, in January 2021 the ... Read More
-
Gastric Cancer Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... COVID-19 pandemic has affected the healthcare systems globally and also had a significant impact on the gastric cancer therapy market. For instance, as per an article published by the Nature Public Health Emergency Collection, in ... Read More
-
North America Cancer Therapy Market- Growth, Trends, and Forecasts (2022 - 2027)
... affected the healthcare systems globally and also has had a significant impact on the cancer therapy market. As per the article published in November 2020 titled "Studies Evaluate Impact of COVID-19 on Cancer Care", by ... Read More
-
Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Ewing Sarcoma (Oncology) pipeline landscape. Ewing's sarcoma is a primary bone cancer that affects mainly children and adolescents. Ewing's sarcoma can occur any time during childhood and young adulthood, but ... Read More
-
Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Endometrial Cancer (Oncology) pipeline landscape. Endometrial cancer is cancer that starts in the endometrium, the lining of the uterus (womb). Endometrial cancer is the most common type of uterine cancer. ... Read More
-
Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Cervical Cancer (Oncology) pipeline landscape. Cervical cancer occurs when abnormal cells on the cervix grow out of control. Most cervical cancer is caused by a virus called human papillomavirus, or ... Read More
-
Middle-East and Africa Cancer Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... period. Global health care services have been severely impacted by the COVID-19 pandemic. Particularly in low-resource countries, the pandemic has disrupted cancer services. As per the article published in October 2021 titled, 'Impact of the ... Read More
-
Cancer Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... is an unprecedented health concern that is impacting the tumor ablation market. For instance, a study titled ‘Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study’ in 2020 reported that A total ... Read More
-
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Leukemia (ALL, Acute Lymphoblastic Leukemia) - Drugs In Development, 2022, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) pipeline landscape. Acute lymphocytic leukemia (ALL) is the cancer of the white ... Read More
-
Targeted Cancer Therapy Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)
... COVID-19 pandemic has affected the healthcare systems globally and significantly impacted the targeted cancer therapy market. As per the article published in Cancer Connect 2020, doctors from Dana Farber Cancer Institute determined that during the ... Read More
-
Europe Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... of the global spread of COVID-19 in early 2020, patients with cancer were designated as a particularly vulnerable subgroup of the population. Cancer patients have been reported to be both at increased risk of contracting ... Read More
-
Metastatic Melanoma Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... had a substantial impact on the metastatic melanoma drugs market initially. The strict lockdowns and government regulations intended to slow down the spread of COVID-19 resulted in a decrease in the treatment of cancer patients ... Read More
-
Cancer Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... healthcare systems and resulted in the interruption of usual care in many healthcare facilities, exposing vulnerable patients with cancer to significant risks. The COVID-19 pandemic had a negative impact on the cancer biomarkers market, owing ... Read More
Research Assistance
